Operational tolerance after liver transplantation
- PMID: 19394103
- DOI: 10.1016/j.jhep.2009.03.006
Operational tolerance after liver transplantation
Abstract
The achievement of an immunosuppression (IS)-free state after transplantation represents the ultimate goal of any immunosuppressive regimen. While clinical operational tolerance (COT) remains the exception after other types of solid organ transplantation, several cases of COT have been described after liver transplantation (LT). Overall, the experience gained so far worldwide demonstrates that COT can be achieved safely in one quarter of selected individuals, irrespective of the immunological background of donor and recipient, patient age, indication for LT, study endpoint, length of the weaning period and of pre/post-weaning follow-up, presence or not of chimerism. However, most transplant physicians still believe that the achievement of COT is still out of reach for the majority of LT recipients because of the potential risk for transplant survival, the non-randomized nature of most of the studies reported so far, and the selective nature of the patients enrolled in such studies, making them non-representative of the whole population of LT recipients. Despite these concerns, the present article demonstrates that this attitude is potentially no longer justified, given the growing evidence that a permanent and stable IS-free state can be achieved in a proportion of individuals who have received a LT for non-immune mediated liver diseases.
Similar articles
-
Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.Clin Transpl. 2011:223-35. Clin Transpl. 2011. PMID: 22755416
-
Finding the right time for weaning off immunosuppression in solid organ transplant recipients.Expert Rev Clin Immunol. 2010 Nov;6(6):879-92. doi: 10.1586/eci.10.71. Expert Rev Clin Immunol. 2010. PMID: 20979553 Review.
-
Liver transplantation without immunosuppression: future perspectives.Ital J Gastroenterol. 1996 May;28(4):246-9. Ital J Gastroenterol. 1996. PMID: 8842842
-
Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.Dig Liver Dis. 2009 May;41(5):350-6. doi: 10.1016/j.dld.2008.09.018. Epub 2008 Nov 28. Dig Liver Dis. 2009. PMID: 19046932
-
[Development of immune tolerance in liver transplantation].Gastroenterol Hepatol. 2011 Mar;34(3):155-69. doi: 10.1016/j.gastrohep.2010.11.007. Epub 2011 Mar 3. Gastroenterol Hepatol. 2011. PMID: 21376423 Review. Spanish.
Cited by
-
Accidental ABO-incompatible pediatric liver transplantation with blood group antigen immune and operational tolerance: a case report with 21 years of follow-up.Korean J Transplant. 2023 Dec 31;37(4):306-309. doi: 10.4285/kjt.23.0070. Korean J Transplant. 2023. PMID: 38153256 Free PMC article.
-
Cell transplantation-based regenerative medicine in liver diseases.Stem Cell Reports. 2023 Aug 8;18(8):1555-1572. doi: 10.1016/j.stemcr.2023.06.005. Stem Cell Reports. 2023. PMID: 37557073 Free PMC article. Review.
-
Leveraging the lymphohematopoietic graft-versus-host reaction (LGVHR) to achieve allograft tolerance and restore self tolerance with minimal toxicity.Immunother Adv. 2023 May 13;3(1):ltad008. doi: 10.1093/immadv/ltad008. eCollection 2023. Immunother Adv. 2023. PMID: 37426630 Free PMC article. Review.
-
Transcriptomic analysis of graft liver provides insight into the immune response of rat liver transplantation.Front Immunol. 2022 Nov 3;13:947437. doi: 10.3389/fimmu.2022.947437. eCollection 2022. Front Immunol. 2022. PMID: 36426354 Free PMC article.
-
Reducing Immunosuppression in Patients with De Novo Lung Carcinoma after Liver Transplantation Could Significantly Prolong Survival.Cancers (Basel). 2022 Jun 1;14(11):2748. doi: 10.3390/cancers14112748. Cancers (Basel). 2022. PMID: 35681728 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous